期刊文献+

早期卵巢上皮性癌和交界性肿瘤保留生育功能相关问题 被引量:7

Fertility-sparing management for early epithelial ovarian cancer and borderline tumors
原文传递
导出
摘要 文章分别对早期卵巢上皮性癌(EOC)及交界性卵巢癌(BOT)年轻患者要求保留生育功能治疗的术式、选择病例标准、术中注意事项、术后相关问题及妊娠结局进行讨论。在对EOC及BOT患者进行保留生育功能手术(FSS)治疗前应与患者充分讨论和交流,使患者充分理解此种术式治疗后的生育潜在可能性和安全性。手术应由有经验的妇瘤医师施行,保证分期手术的准确性;术后多学科(妇科肿瘤医师、生殖医学专家、产科医师)会诊,共同治疗、随访,是获得妊娠良好结局和患者安全的保证。 In this paper we’ll discuss the fertility-sparing surgery in EOC and BOT separatelly. The surgical procedures of FSS, the carefully selected patients, the other important factors which should be paid attention to during staging surgery or postoperation care and the outcome of pregnancy of FSS are discussed. It is emphasized that the discussion about this conservative treatment with patients should be fully, before surgery, patients have to understand the conservative surgery treatment for EOC early stage, the potential possibility of pregnancy and the safety. The FSS should be performed by a gynecologic oncologist in order to get a staging exactly.Counseling with gynecologic oncologist, reproductive experts, and obstetrician, multi disciplinary treatment and follow up are important factors to get good outcome of FSS and safety for patient.
作者 彭芝兰
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2013年第5期334-339,共6页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 卵巢癌 交界性肿瘤 保留生育功能 ovarian cancer borderline or low malignant potential tumor fertility-sparing
  • 相关文献

参考文献34

  • 1Leblanc E, Narducci F, Ferron G, et al. Indications and teach- ing of fertility preservation in the surgical management of gyneco- logic malignancies : European perspective [ J ]. Gynecol Oncol, 2009,114 : 532-536.
  • 2Rodriguez-Wallberg KA, Oktay K. Options on fertility preserva- tion in female cancer patients[ J. Cancer Treat Rev,2012,38 : 354-361.
  • 3Fleming GF, Ronnett BM, Seidman J. Epithelial ovarian cancer [ M]// Barakat RR, Markman M, Randall ME, eds. Principles and practice of gynecologic oncology. 5th ed. Philadelphia: Lip- pincott Williams & Wikins,2009:763-836.
  • 4Schilder JM,Thompson AM, DePriest PD, et al. Outcome of re- productive age women with stage IA of IC invasive epithelial ovar- ian cancer treated with fertility-sparing therapy[ J]. Gynecol On- col, 2002, 87 : 1-7.
  • 5Trimbos JB,van der Burg ME. Adjuvant chemotherapy in pa- tients operated on for early ovarian carcinoma[J]. Ned Tijdschr Geneeskd, 2004,148(18) :874-878.
  • 6Lu KH, Skates S,Bevers TB, eta!. A prospective U. S. ovarian cancer screening study using the risk of ovarian cancer algorithm (ROCA) [J]. J Clin Oncol, 2010,28(Suppl 15) : 2003.
  • 7Jacob F, Meier M, Caduff R, et al. No benefit from combining HFA and CA125 as ovarian tumor markers in a clinical setting [J]. Gynecol Oncol, 2011,121:487-491.
  • 8Moore RG, Miller MC, Disilvestro P, et al. Evaluation of the di- agnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass[ J]. Obstet Gynecol, 2011,118:208- 288.
  • 9Du Bois A, Quinn M, Thigpen T, et al. 2004 consensus state- ments on the management of ovarian cancer: final document ofthe 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference ( GCIG OCCC 2004 ) [ J ]. Ann Oncol, 2005,16 ( Suppl 8 ) :viii7-viiil2.
  • 10Earle CC, Schrag D, Neville BA et al. Effect of surgeon spe- cialty on processes of care and outcomes for ovarian cancer pa- tients[ J]. J Natl Cancer Inst, 2006,98 : 172-180.

二级参考文献20

  • 1曾定元,沈铿,黄惠芳,吴鸣,潘凌亚,杨佳欣,郎景和.卵巢恶性肿瘤患者保留生育功能治疗的预后及相关因素分析[J].中华医学杂志,2005,85(36):2562-2565. 被引量:13
  • 2丁志明,谢幸.上皮性卵巢癌患者生育功能的保留[J].中国实用妇科与产科杂志,2006,22(4):247-249. 被引量:1
  • 3David M. Gershenson "the continuum of serous ovarian tumors of low malignant potential and low-grade serous carcinoma of the o- vary rare and umcommon gynecological cancer" eds [ M ]. Lon- don Newyork:Springer, 2011:105-111.
  • 4Berek J, Fried M, Neville F. Hacker "epithelial ovarian, fallo- pian tube, and peritoneal cancer" berek & haekers gynecologic oncology eded by jonathan s berek and neville f hackers [ M ]. Newyork London: Fifth Edition Lippineott William & Wilkins, 2011:443-448.
  • 5" Borderline Epithelial Ovarian Cancer (Low-Malignant Poten- tial) NCCN Clinical Practice Guidelines in Oncology Ovarian Cancer including Fallopian Tuke Cancerand Primary Peritoneal Cancer,2011, OV-7.
  • 6Lalwani N, Anampady KPS, Vikram R, et al. Current update on borderline ovarian neoplasms[ J]. AJR, 2010,194:237-241.
  • 7Acs G. Serous and mucinous borderline (low malignant poten- tial) tumors of the ovary [ J ]. Am J Clin Pathol, 2005,123 ( sup- pl) :S13-S17.
  • 8Joo-Hyun Nam. Borderline ovarian tumors and fertility[ J]. Cur- rent Opinion in Obstetrics and Gynecology, 2010,22:227-234.
  • 9Wong HF, Low JJH, Chua Y, et al. Ovarian tumors of borderline malignancy : a review of 247 patients from 1991 to 2004[ J]. Int J Gynecol Cancer, 2007,17:342-349.
  • 10Shih KK, Zhou Q, Huh J, et al. Risk factrors recurrence of o- varian borderline tumors [ J ]. Gynecol Oncol, 2011, 120 : 480- 484.

共引文献4

同被引文献44

  • 1段微,范逢晓.保留生育功能手术对卵巢交界性肿瘤临床治疗效果的影响[J].中国实用妇科与产科杂志,2006,22(6):449-450. 被引量:11
  • 2Stoop D, Cobo A, Silber S, et al. Fertility preservation for age-related fertility decline [ J ]. Lancet, 2014, 384 (9950) : 1311-1319.
  • 3Hoshi M, Oebisu N, Takada J, et al. Pre- chemotherapy preservation of fertility in male patients with high- grade malignant bone and soft tissue tumors [J]. Mol Clin Oncol, 2014, 2 (6): 1111-1114.
  • 4Qiu J,Yu Y,Fu Y,et al.Preoperative plasma fibrinogen,platelet count and prognosis in epithelial ovarian cancer[J].J Obstet Gynaecol Res,2012,38:651-657.
  • 5Zheng S,Liu Y,Jiao Y,et al.Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets[J].Oncol Lett,2012,3:497-502.
  • 6Du J,Zheng JH,Chen XS,et al.High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma[J].Int J Clin Oncol,2013,18:517-523.
  • 7Wang H,Gao J,Bai M,et al.The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer[J].Platelets,2014,25:382-387.
  • 8Yoneyama T,Ohtsuki S,Ono M,et al.Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylatedα-fibrinogen in plasma for pancreatic cancer diagnosis[J].J Proteome Res,2013,12:753-762.
  • 9Egan K,Crowley D,Smyth P,et al.Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells[J].PLo S One,2011,6:e26125.
  • 10薛峰.卵巢肿瘤的临床病理分析[J].中国现代医生,2010,48(32):98-99. 被引量:6

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部